Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 5/20 | 0.48 |
| ▸ | CYP4A11 | Q02928 | 5/20 | 0.48 |
| ▸ | ATR | Q13535 | 15/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19153518 | 0.82 | CYP4F2 (0.46) | CYP4F2CYP4A11ATR | |
| SCHEMBL30763853 | 0.82 | ATR (0.48) | CYP4F2CYP4A11ATR | |
| SCHEMBL12092426 | 0.80 | CYP4F2 (0.52) | CYP4F2CYP4A11ATR | |
| SCHEMBL30184483 | 0.77 | CYP4F2 (0.47) | CYP4F2CYP4A11ATR | |
| SCHEMBL19879311 | 0.77 | ATR (0.37) | CYP4F2CYP4A11ATR | |
| SCHEMBL19866178 | 0.77 | RET (0.39) | CYP4F2CYP4A11ATR | |
| SCHEMBL13734367 | 0.77 | CYP4F2 (0.53) | CYP4F2CYP4A11ATR | |
| SCHEMBL26986513 | 0.76 | CYP4F2 (0.48) | CYP4F2CYP4A11ATR | |
| SCHEMBL2815892 | 0.76 | KCNN4 (0.40) | CYP4F2CYP4A11ATR | |
| SCHEMBL18758225 | 0.76 | CYP4F2 (0.47) | CYP4F2CYP4A11ATR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11825741-B2 | Organic compound, organic light emitting diode and organic light emitting device including the organic compound | LG DISPLAY CO., LTD. (KR) | 2023-11-21 | — | — | US | disclosed |
| US-11825741-B2 | Organic compound, organic light emitting diode and organic light emitting device including the organic compound | LG DISPLAY CO., LTD. (KR) | 2023-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11825741-B2 | Organic compound, organic light emitting diode and organic light emitting device including the organic compound | OCIAD2, OCIAD1, EML4 | CYP4F2 2886/4885CYP4A11 2584/4885ATR 1980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.